Intriguingly, the overexpression of Fn14, which occurs in some types of cancers, can also activate downstream signaling pathways without requiring stimulation by the TWEAK cytokine (Winkles, 2008; Burkly, 2014; Tajrishi et al, 2014). This evidence concerns the gene TNFRSF12A and cancer.